Cell No. : Cell Name
RCB2618 : BCL1-B20
update : 2024/08/14
|
| Comment | Mouse cell line derived from B cell leukemia. TKG0435 (Deposited from Tohoku Univ.). |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Fukuda, Hiroshi
|
| Year of deposit |
2007
|
| Original cell |
TKG0435
|
| Animal |
_mouse
< Mammals
|
| Strain name |
BALB/c
|
| Tissue |
B cell leukemia
|
| Disease name |
spontaneous B cell leukemia
|
| Classification |
cancer
|
| History |
Cell Resource Center for Biomedical Research, Tohoku University（TKG0435）
|
|
Lifespan |
infinite
|
| Morphology |
other
|
| Cellosaurus(Expasy) |
CVCL_B994
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Culture medium |
|
RPMI1640 + 10% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
| SC frequency |
|
Subculture : 1-2 times/week, Medium Renewal : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma/Acholeplasma |
|
(-)
|
| SSLP(mouse) |
|
OK
|
| Isozyme |
|
LD, NP
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
8
|
| User's Publication |
3
|
| Reference |
|
5198
Tominaga A, Takahashi T, Kikuchi Y, Mita S, Naomi S, Harada N, Yamaguchi N, Takatsu K.
Role of carbohydrate moiety of IL-5. Effect of tunicamycin on the glycosylation of IL-5 and the biologic activity of deglycosylated IL-5.
J Immunol
1990
144(4):1345-52
PubMed ID: 2303708
|
|
5200
Hitoshi Y, Yamaguchi N, Mita S, Sonoda E, Takaki S, Tominaga A, Takatsu K.
Distribution of IL-5 receptor-positive B cells. Expression of IL-5 receptor on Ly-1(CD5)+ B cells.
J Immunol
1990
144(11):4218-25
PubMed ID: 1692859
|
|
5201
Murata Y1, Yamaguchi N, Hitoshi Y, Tominaga A, Takatsu K.
Interleukin 5 and interleukin 3 induce serine and tyrosine phosphorylations of several cellular proteins in an interleukin 5-dependent cell line.
Biochem Biophys Res Commun
1990
173(3):1102-8
PubMed ID: 2125214
DOI: 10.1016/s0006-291x(05)80899-x
|
|
5202
Yamaguchi N, Hitoshi Y, Mita S, Hosoya Y, Murata Y, Kikuchi Y, Tominaga A, Takatsu K.
Characterization of the murine interleukin 5 receptor by using a monoclonal antibody.
Int Immunol
1990
2(2):181-7
PubMed ID: 2088484
DOI: 10.1093/intimm/2.2.181
|
|
5206
Migita M, Yamaguchi N, Katoh S, Mita S, Matsumoto R, Sonoda E, Tsuchiya H, Matsuda I, Tominaga A, Takatsu K.
Elevated expression of proto-oncogenes during interleukin-5-induced growth and differentiation of murine B lineage cells.
Microbiol Immunol
1990
34(11):937-52
PubMed ID: 2090920
DOI: 10.1111/j.1348-0421.1990.tb01072.x
|
|
1985
Mita S, Tominaga A, Hitoshi Y, Sakamoto K, Honjo T, Akagi M, Kikuchi Y, Yamaguchi N, Takatsu K
Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines.
Proc Natl Acad Sci U S A
1989
86:2311-5
PubMed ID: 2784567
DOI: 10.1073/pnas.86.7.2311
|
|
4819
Mita S, Harada N, Naomi S, Hitoshi Y, Sakamoto K, Akagi M, Tominaga A, Takatsu K.
Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication.
J Exp Med
1988
168(3):863-78
PubMed ID: 3262707
DOI: 10.1084/jem.168.3.863
|
|
5199
Strober S, Gronowicz ES, Knapp MR, Slavin S, Vitetta ES, Warnke RA, Kotzin B, Schröder J.
Immunobiology of a spontaneous murine B cell leukemia (BCL1).
Immunol Rev
1979
48:169-95
PubMed ID: 121100
DOI: 10.1111/j.1600-065x.1979.tb00303.x
|
| User's Publication |
|
7581
Hiroi M, Sakaeda Y, Yamaguchi H, Ohmori Y.
Anti-inflammatory cytokine interleukin-4 inhibits inducible nitric oxide synthase gene expression in the mouse macrophage cell line RAW264.7 through the repression of octamer-dependent transcription.
Mediators Inflamm.
2013
2013:369693
PubMed ID: 24459328
DOI: 10.1155/2013/369693
|
|
7699
Yokoi H, Kasahara M, Mori K, Ogawa Y, Kuwabara T, Imamaki H, Kawanishi T, Koga K, Ishii A, Kato Y, Mori KP, Toda N, Ohno S, Muramatsu H, Muramatsu T, Sugawara A, Mukoyama M, Nakao K.
Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
Kidney Int.
2012
81:160-9
PubMed ID: 21881556
DOI: 10.1038/ki.2011.305
|
|
4847
Cho Y, Honda S, Yoshizawa Y, Takagaki K, Usui K, Shibuya A.
Requirement of the cytoplasmic portion for dimer formation of Fcalpha/micro receptor expressed on cell surface.
Mol Immunol
2010
47(4):878-82
PubMed ID: 19945166
DOI: 10.1016/j.molimm.2009.10.016
|
Back
Top
CELL BANK Website
